Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
770.00 | -48.81% | -27.8% | 694,320.6 | 0.67% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
154.64 | 0% | 0% | 371,302.46 | 3.21% | 2.71% |
|
NYSE:MRK
Merck
|
131.19 | -9.8% | 3.42% | 331,493.69 | 2.35% | -19.03% |
|
NYSE:PFE
Pfizer
|
28.64 | 7.37% | 37.31% | 163,877.87 | 5.81% | -9.31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
445.21 | -1.09% | 6.74% | 113,708.64 | 0% | 30.14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
982.29 | -28.55% | -22.46% | 104,431.01 | 0% | 13.9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61.44% | 71.76% | 89,415.39 | 5.44% | 13.54% |
|
NYSE:ZTS
Zoetis
|
174.06 | 27.37% | 43.14% | 79,263.03 | 0.99% | 11.19% |
|
NasdaqGS:ALNY
Alnylam Pharmaceuticals Inc
|
149.40 | 0% | 0% | 19,128.09 | 0% | 0% |
|
NYSE:BAX
Baxter International Inc
|
35.25 | 83.19% | 110.83% | 17,921.94 | 3.3% | -3.14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.02 | 5.13% | 15.66% | 13,324.53 | 4.34% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
272.22 | -10.71% | -1.33% | 11,803.71 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
55.25 | -57.27% | -6.76% | 10,100.49 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
59.92 | 0% | 0% | 6,707.63 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
37.62 | -,156.68% | -,149.23% | 5,756.54 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
156.63 | -9.31% | -0.59% | 5,026.29 | 0.51% | 5.85% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
217.17 | 0% | 0% | 4,409.78 | 0% | 0% |
|
NYSE:PRGO
Perrigo Co PLC
|
30.10 | 35.17% | 58.31% | 4,186.4 | 3.65% | -10.73% |
|
NasdaqGS:NEOG
Neogen
|
13.41 | 133.55% | 233.03% | 2,692.43 | 0% | -1.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
27.54 | -34.78% | -10.92% | 2,552.83 | 0% | 2.03% |
